Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Rizatriptan, sold under the brand name Maxalt among others, is a medication used for the treatment of migraine headaches. It is taken by mouth. It can also be applied on the tongue. It is a serotonin (5-HT) 1B/1D receptor agonist (triptan).
The analysis highlights History and Applications as prominent areas in the source structure around Rizatriptan.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Rizatriptan shows recurring relationship patterns in the source. For example, Rizatriptan → AU: S4 (Prescription only) / S3, CA: ℞-only, In general: ℞ (Prescription only), US: ℞-only Another extracted example is Rizatriptan → DMT, N-dimethyltryptamine, The. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
medication use serotonin effects triptan mouth receptor include migraine agonist brand medical maxalt hours names headaches side may available interaction
TTTA extracted 42 structured relationships around Rizatriptan. Examples in this analysis include Rizatriptan → 3D model (JSmol) → Interactive image and Rizatriptan → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Rizatriptan | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Rizatriptan | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Rizatriptan | ATC code | N02CC04 (WHO) | 1.00 | infobox |
| Rizatriptan | Bioavailability | 45% | 1.00 | infobox |
| Rizatriptan | CAS Number | 145202-66-0 Y | 1.00 | infobox |
| Rizatriptan | ChEBI | CHEBI:48273 Y | 1.00 | infobox |
| Rizatriptan | ChEMBL | ChEMBL905 Y | 1.00 | infobox |
| Rizatriptan | ChemSpider | 4900 Y | 1.00 | infobox |
| Rizatriptan | CompTox Dashboard (EPA) | DTXSID2023565 | 1.00 | infobox |
| Rizatriptan | Drug class | Serotonin 5-HT1B, 5-HT1D, 5-HT1E, and 5-HT1F receptor agonist; Antimigraine agent; Triptan | 1.00 | infobox |
| Rizatriptan | DrugBank | DB00953 Y | 1.00 | infobox |
| Rizatriptan | ECHA InfoCard | 100.243.719 | 1.00 | infobox |
| Rizatriptan | Elimination half-life | 2–3 hours | 1.00 | infobox |
| Rizatriptan | Excretion | 82% urine; 12% feces | 1.00 | infobox |
| Rizatriptan | Formula | C15H19N5 | 1.00 | infobox |
| Rizatriptan | IUPHAR/BPS | 51 | 1.00 | infobox |
| Rizatriptan | KEGG | D00675 Y | 1.00 | infobox |
| Rizatriptan | Legal status | AU: S4 (Prescription only) / S3 | 1.00 | infobox |
| Rizatriptan | Legal status | CA: ℞-only | 1.00 | infobox |
| Rizatriptan | Legal status | US: ℞-only | 1.00 | infobox |
| Rizatriptan | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Rizatriptan | License data | US DailyMed: Rizatriptan | 1.00 | infobox |
| Rizatriptan | MedlinePlus | a601109 | 1.00 | infobox |
| Rizatriptan | Metabolism | By monoamine oxidase | 1.00 | infobox |
| Rizatriptan | Molar mass | 269.352 g·mol−1 | 1.00 | infobox |
| Rizatriptan | Other names | L-705126; L705126; MK-0462; MK0462; MK-462; MK462; 5-(1H-1,2,4-Triazol-1-ylmethyl)-N,N-dimethyltryptamine; 5-(1H-1,2,4-Triazol-1-ylmethyl)-DMT | 1.00 | infobox |
| Rizatriptan | Pregnancy category | AU: B1 | 1.00 | infobox |
| Rizatriptan | Protein binding | 14% | 1.00 | infobox |
| Rizatriptan | PubChem CID | 5078 | 1.00 | infobox |
| Rizatriptan | Routes of administration | By mouth | 1.00 | infobox |
The concept neighborhoods around Rizatriptan bring nearby vocabulary together. In this analysis, examples include Medical, 5-ht1b and 5-ht1d. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Rizatriptan, one of the stronger structural bridges in this analysis connects Rizatriptan with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Rizatriptan to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Rizatriptan · EN edition · Analysis: TopicsToTalkAbout